Oncolytics Biotech Inc. Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Jul 22, 2025 · CIK: 1129928
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
Related Tickers: ONCY
TL;DR
ONCOLYTICS BIOTECH (ONCY) files 6-K, confirms 20-F annual report filing.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on July 22, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a pharmaceutical preparations company and will file its annual reports under Form 20-F.
Why It Matters
This filing indicates Oncolytics Biotech Inc. is meeting its reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and not indicating any new material events or financial distress.
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Registrant
- July 2025 (date) — Reporting period
- 20250722 (date) — Filing date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 for the month of July 2025.
Which annual report form does Oncolytics Biotech Inc. file?
Oncolytics Biotech Inc. indicates it files its annual reports under cover of Form 20-F.
What is the filing date of this report?
This report was filed on July 22, 2025.
Where is Oncolytics Biotech Inc. located?
Oncolytics Biotech Inc. is located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
What is the SIC code for Oncolytics Biotech Inc.?
The Standard Industrial Classification (SIC) code for Oncolytics Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 22, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).